Jui‐Ling Hsu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Synthesis and Biological Activity
- Pharmacology top 10%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 4
- PI3K/AKT/mTOR signaling in cancer 4
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 3
- Oncology 7
- Co-authors
- Jih‐Hwa Guh (28 shared papers)Lih‐Ching Hsu (20 shared papers)Chau‐Jong Wang (3 shared papers)Fen‐Pi Chou (3 shared papers)Yih‐Shou Hsieh (1 shared paper)Yunn‐Fang Ho (4 shared papers)She‐Hung Chan (7 shared papers)Shun-Chieh Young (2 shared papers)
- Journals
- The Prostate (5 papers)Frontiers in Pharmacology (4 papers)Molecules (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Toxicology and Applied Pharmacology (2 papers)
- Partner nations
- TaiwanUnited StatesRussia
In The Last Decade
Jui‐Ling Hsu
30 papers receiving 570 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 109
- Pharmacology 66
- Pharmacology 123
- Toxicology 23
- Molecular Biology 304
Countries citing papers authored by Jui‐Ling Hsu
This map shows the geographic impact of Jui‐Ling Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui‐Ling Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui‐Ling Hsu more than expected).
Fields of papers citing papers by Jui‐Ling Hsu
This network shows the impact of papers produced by Jui‐Ling Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui‐Ling Hsu. The network helps show where Jui‐Ling Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jui‐Ling Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 141 | |
| 2 | 2019 | 39 | |
| 3 | 2006 | 34 | |
| 4 | 2020 | 32 | |
| 5 | 2013 | 32 | |
| 6 | 2009 | 31 | |
| 7 | 2012 | 26 | |
| 8 | 2014 | 25 | |
| 9 | 2005 | 24 | |
| 10 | 2020 | 23 | |
| 11 | 2022 | 20 | |
| 12 | 2012 | 19 | |
| 13 | 2019 | 18 | |
| 14 | 2012 | 17 | |
| 15 | 2018 | 14 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2011 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2021 | 8 |
About Jui‐Ling Hsu
Jui‐Ling Hsu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Toxicology, having authored 32 papers that have together received 581 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), DNA Repair Mechanisms (4 papers), Cancer Mechanisms and Therapy (4 papers), Cancer therapeutics and mechanisms (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (109 citations), Pharmacology (66 citations), Pharmacology (123 citations), Toxicology (23 citations) and Molecular Biology (304 citations). Jui‐Ling Hsu has collaborated with scholars based in Taiwan, United States and Russia. Frequent co-authors include Jih‐Hwa Guh, Lih‐Ching Hsu, Chau‐Jong Wang, Fen‐Pi Chou, Yih‐Shou Hsieh, Yunn‐Fang Ho, She‐Hung Chan, Shun-Chieh Young, Hsun‐Shuo Chang and Shih‐Ping Liu. Their work appears in journals such as The Prostate, Frontiers in Pharmacology, Molecules, Naunyn-Schmiedeberg s Archives of Pharmacology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.